Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.27 | 3e-12 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.23 | 2e-09 |
mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.22 | 3e-09 |
mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.32 | 2e-07 |
mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.29 | 9e-07 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-06 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.19 | 6e-06 |
mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.28 | 6e-06 |
mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-05 |
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |